Cardiovascular R & D platform for preclinical drug development
A privately owned Hungarian SME is offering innovative and cost-effective preclinical R & D services focusing on cardiovascular diseases (e.g. infarction, heart failure, arrhythmias, sepsis) efficacy, safety, and pharmacokinetic animal models, including co-morbidity, custom designed and large animal models as well.
The company is looking for partners that are interested in out-sourcing their preclinical pharmacology projects. The company is open for joint venture or technical cooperation.
Closing date: 22/01/2015